Glialia

Glialia is owned by EPITECH Group SpA, headquartered in Italy. No. The ultimate owner of Glialia, EPITECH Group SpA, is headquartered in Italy, not in the United States.

EPITECH Group (Epirical Technological Group) is an Italian pharmaceutical and biotechnology company specializing in the research and development of biological modulators for the treatment of inflammatory and neurodegenerative disorders.